Peptides that block human immunodeficiency virus and methods of use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 6, 1997
Issued Date -
N/A
app pub date -
Jun 26, 1995
filing date -
Aug 22, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
It has now been found that relatively short peptides such as the tripeptide glycyl-prolyl-glycine are able to effectively inhibit HIV infection of cells and syncytia formation between HIV infected and and non-infected cells. The peptides are suitable for therapy of patients infected with HIV and in prevention of HIV infection.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully